Pharmacokinetics-Pharmacodynamics Analysis of Bicyclic 4-Nitroimidazole Analogs in a Murine Model of Tuberculosis
出版年份 2014 全文链接
标题
Pharmacokinetics-Pharmacodynamics Analysis of Bicyclic 4-Nitroimidazole Analogs in a Murine Model of Tuberculosis
作者
关键词
-
出版物
PLoS One
Volume 9, Issue 8, Pages e105222
出版商
Public Library of Science (PLoS)
发表日期
2014-08-21
DOI
10.1371/journal.pone.0105222
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Importance of Relating Efficacy Measures to Unbound Drug Concentrations for Anti-Infective Agents
- (2013) D. Gonzalez et al. CLINICAL MICROBIOLOGY REVIEWS
- Indolcarboxamide Is a Preclinical Candidate for Treating Multidrug-Resistant Tuberculosis
- (2013) S. P. S. Rao et al. Science Translational Medicine
- Dose-Ranging Comparison of Rifampin and Rifapentine in Two Pathologically Distinct Murine Models of Tuberculosis
- (2012) Ian M. Rosenthal et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- 14-day bactericidal activity of PA-824, bedaquiline, pyrazinamide, and moxifloxacin combinations: a randomised trial
- (2012) Andreas H Diacon et al. LANCET
- High-Sensitivity MALDI-MRM-MS Imaging of Moxifloxacin Distribution in Tuberculosis-Infected Rabbit Lungs and Granulomatous Lesions
- (2011) Brendan Prideaux et al. ANALYTICAL CHEMISTRY
- Overton's Rule Helps To Estimate the Penetration of Anti-Infectives into Patients' Cerebrospinal Fluid
- (2011) Marija Djukic et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacokinetics and Pharmacodynamics of TMC207 and ItsN-Desmethyl Metabolite in a Murine Model of Tuberculosis
- (2011) Marie-Claude Rouan et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacokinetic Evaluation of the Penetration of Antituberculosis Agents in Rabbit Pulmonary Lesions
- (2011) Maria C. Kjellsson et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Why Do We Use 600 mg of Rifampicin in Tuberculosis Treatment?
- (2011) J. van Ingen et al. CLINICAL INFECTIOUS DISEASES
- Challenges and opportunities in developing novel drugs for TB
- (2011) Takushi Kaneko et al. Future Medicinal Chemistry
- Synthesis and Structure–Activity Relationships of Varied Ether Linker Analogues of the Antitubercular Drug (6S)-2-Nitro-6-{[4-(trifluoromethoxy)benzyl]oxy}-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine (PA-824)
- (2011) Andrew M. Thompson et al. JOURNAL OF MEDICINAL CHEMISTRY
- Structure–Activity Relationships of Antitubercular Nitroimidazoles. 3. Exploration of the Linker and Lipophilic Tail of ((S)-2-Nitro-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazin-6-yl)-(4-trifluoromethoxybenzyl)amine (6-Amino PA-824).
- (2011) Joseph Cherian et al. JOURNAL OF MEDICINAL CHEMISTRY
- Structure–Activity Relationships for Amide-, Carbamate-, And Urea-Linked Analogues of the Tuberculosis Drug (6S)-2-Nitro-6-{[4-(trifluoromethoxy)benzyl]oxy}-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine (PA-824)
- (2011) Adrian Blaser et al. JOURNAL OF MEDICINAL CHEMISTRY
- Early Bactericidal Activity and Pharmacokinetics of PA-824 in Smear-Positive Tuberculosis Patients
- (2010) A. H. Diacon et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- PA-824 Exhibits Time-Dependent Activity in a Murine Model of Tuberculosis
- (2010) Zahoor Ahmad et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The nitroimidazooxazines (PA-824 and analogs): structure–activity relationship and mechanistic studies
- (2010) William A Denny et al. Future Medicinal Chemistry
- Class-dependent relevance of tissue distribution in the interpretation of anti-infective pharmacokinetic/pharmacodynamic indices
- (2010) April Barbour et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- The effect of plasma protein binding on in vivo efficacy: misconceptions in drug discovery
- (2010) Dennis A. Smith et al. NATURE REVIEWS DRUG DISCOVERY
- A chemical genetic screen in Mycobacterium tuberculosis identifies carbon-source-dependent growth inhibitors devoid of in vivo efficacy
- (2010) Kevin Pethe et al. Nature Communications
- Safety, Tolerability, and Pharmacokinetics of PA-824 in Healthy Subjects
- (2009) A. M. Ginsberg et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Structure−Activity Relationships of Antitubercular Nitroimidazoles. 2. Determinants of Aerobic Activity and Quantitative Structure−Activity Relationships
- (2009) Pilho Kim et al. JOURNAL OF MEDICINAL CHEMISTRY
- Structure−Activity Relationships of Antitubercular Nitroimidazoles. 1. Structural Features Associated with Aerobic and Anaerobic Activities of 4- and 5-Nitroimidazoles
- (2009) Pilho Kim et al. JOURNAL OF MEDICINAL CHEMISTRY
- Synthesis and Structure−Activity Studies of Biphenyl Analogues of the Tuberculosis Drug (6S)-2-Nitro-6-{[4-(trifluoromethoxy)benzyl]oxy}-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine (PA-824)
- (2009) Brian D. Palmer et al. JOURNAL OF MEDICINAL CHEMISTRY
- Trend Analysis of a Database of Intravenous Pharmacokinetic Parameters in Humans for 670 Drug Compounds
- (2008) R. S. Obach et al. DRUG METABOLISM AND DISPOSITION
- PA-824 Kills Nonreplicating Mycobacterium tuberculosis by Intracellular NO Release
- (2008) R. Singh et al. SCIENCE
- Rising standards for tuberculosis drug development
- (2008) Tanjore S. Balganesh et al. TRENDS IN PHARMACOLOGICAL SCIENCES
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now